XML 59 R48.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-based Compensation (Details) - Schedule of stock option activity
9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Schedule of stock option activity [Abstract]  
Number of Options, Outstanding at December 31, 2019 (in Shares) | shares 136,489
Weighted Average Exercise Price Per Share, Outstanding at December 31, 2019 $ 28.00
Weighted Average Remaining Contractual Term (years), Outstanding at December 31, 2019 3 years 328 days
Aggregate Intrinsic Value, Outstanding at December 31, 2019 (in Dollars) | $ [1]
Number of Options, Granted (in Shares) | shares 300,206
Weighted Average Exercise Price Per Share, Granted $ 1.94
Weighted Average Remaining Contractual Term (years), Granted 4 years 292 days
Aggregate Intrinsic Value, Granted [1]
Weighted Average Exercise Price Per Share, Exercised
Aggregate Intrinsic Value, Exercised (in Dollars) | $ [1]
Number of Options, Forfeited (in Shares) | shares (9,125)
Weighted Average Exercise Price Per Share, Forfeited
Aggregate Intrinsic Value, Forfeited [1]
Weighted Average Exercise Price Per Share, Expired
Aggregate Intrinsic Value, Exercised, Expired [1]
Number of Options, Outstanding at September 30, 2020 (in Shares) | shares 427,570
Weighted Average Exercise Price Per Share, Outstanding at September 30, 2020 $ 10.25
Weighted Average Remaining Contractual Term (years), Outstanding at September 30, 2020 3 years 328 days
Aggregate Intrinsic Value, Outstanding at September 30, 2020 (in Dollars) | $ [1]
Number of Options, Outstanding, Exercisable at September 30, 2020 (in Shares) | shares 115,655
Weighted Average Exercise Price Per Share, Exercisable at September 30, 2020 $ 25.39
Weighted Average Remaining Contractual Term (years), Exercisable at September 30, 2020 2 years 6 months
Aggregate Intrinsic Value, Outstanding, Exercisable at September 30, 2020 (in Dollars) | $ [1]
[1] The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company’s stock and the exercise price of the underlying options. The estimated stock values used in the calculation were $1.88 and $11.00 per share for the nine months ended September 30, 2020 and the year ended December 31, 2019, respectively.